NAGE
Niagen Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.99
−0.17%Forward multiples
Based on analyst estimates
- P/E forward
- 24.31x
- P/E 2026E
- 20.94x
- P/E 2027E
- 19.49x
- P/E 2028E
- 12.08x
- P/S forward
- 1.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.40x
- PEG TTM
- —
- Price / book
- 2.87x
- Price / sales
- 1.83x
- Price / cash flow
- 39.77x
Enterprise value
- Enterprise value
- $172.2M
- EV / sales
- 1.33x
- EV / EBITDA
- 9.32x
- EV / EBIT
- 19.99x
- Market cap
- $236.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026